Oseltamivir resistance in influenza A (H5N1) infection.
Ravindra K
RK
Gupta
Jonathan S
JS
Nguyen-Van-Tam
D000081:Acetamides / Q000627:therapeutic use*; D000280:Administration, Inhalation; D000284:Administration, Oral; D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy* / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans / Q000627:therapeutic use*; D012794:Sialic Acids / Q000627:therapeutic use*; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir